AMRN
NCM 股策精挑入选日 2026-06-19 · 入选 69 天基本信息
成交结构
基于近 60 日量价数据观察资金强弱。
交易信号历史
按时间回看该股票被模型捕捉到的买点信号。
| 信号日期 | 模型来源 | 评分/强度 | 信号价格 | 止损价 | 止盈价 | 当前表现 | 操作结论 |
|---|---|---|---|---|---|---|---|
| 2026-07-01 | 综合评分 | 66 | $15.94 | $14.57 | $18.69 | -12.3% | 可买入 |
| 2026-06-30 | 综合评分 | 66 | $15.92 | $14.55 | $18.67 | -12.2% | 可买入 |
| 2026-06-29 | 综合评分 | 66 | $15.91 | $14.52 | $18.68 | -12.1% | 可买入 |
| 2026-06-19 | 动量强势 | +nan% | $16.03 | $14.48 | $19.12 | -12.8% | 可买入 |
| 2026-06-16 | 动量强势 | +nan% | $15.35 | $13.51 | $19.03 | -8.9% | 可买入 |
公司简介
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
最新资讯
